In order to explore the structural requirements for cannabinoid activi
ty we have been involved in the design and synthesis of stereochemical
ly defined high affinity probes for the cannabinoid receptor. This eff
ort has involved the development of irreversible ligands which will al
low us to obtain detailed information on the cannabinoid receptor acti
ve site(s). The irreversible ligands, which incorporate highly reactiv
e functional groups in a strategic position of the ligand, may form co
valent bonds with amino acid residues at the receptor active site or i
n the neighborhood of this site. We shall discuss the biochemical prop
erties of one of these probes, which incorporates the electrophilic is
othiocyanate group into the structure of the highly potent cannabinoid
agonist (-)-1',1'-dimethylheptyl-Delta(8)-THC. This ligand, '-isothio
cyanato-1',1'-dimethylheptyl-Delta(8)-THC (7'-NCS-DMH-Delta(8)-THC), w
as evaluated for its affinity for cannabinoid binding sites using rat
forebrain membrane preparations and found to have an apparent IC50 val
ue of 660 pM. Incubation of the membrane preparation with a ligand con
centration of five times the apparent IC50 resulted in the irreversibl
e occupation of nearly all of the receptor specific binding sites.